Salt-Sensitivity and Immunity Cell Activation (NCT03753204) | Clinical Trial Compass
Active — Not RecruitingPhase 1/2
Salt-Sensitivity and Immunity Cell Activation
United States20 participantsStarted 2021-09-01
Plain-language summary
Salt-sensitive hypertension affects nearly 50% of the hypertensive and 25% of the normotensive population, and strong evidence indicates that reducing salt intake decreases blood pressure and cardiovascular events. The precise mechanisms of how dietary salt contributes to blood pressure elevation, renal injury, and cardiovascular disease remains unclear. Our data indicated that monocytes exhibit salt sensitivity, and the investigators hypothesize that of salt sensitivity of these and similar immune cells correlate with the hypertensive response to salt intake. Currently, the research tools for diagnosing salt-sensitivity are costly, time consuming and laborious. In this study the investigators will identify monocyte salt-sensitivity as a marker of salt-sensitive hypertension.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* We will perform a pilot analysis in 20 hypertensive subjects controlled for gender (50% men, 50% women), age (18-60 years),
* New or pre-existing diagnosis of essential hypertension defined as systolic blood pressure \>140 mmHg or \>90 mmHg diastolic or taking antihypertensive medications regardless of current blood pressure.
* BMI (18.5-24.9).
* Only subjects who give informed consent will be studied.
Exclusion Criteria:
* Acute cardiovascular event(s) within the previous 6 months
* Claustrophobia precluding obtaining an MRI
* Inability to understand the nature, scope, and possible consequences of the study or to participate in/comply with the protocol.
* Current excessive alcohol or illicit drug use.
* Blood pressure below the inclusion criteria levels after discontinuation of therapy
* Presence of metal implants such as artificial joints.
* Concomitant diabetes mellitus, type I or II.
* Autoimmune disease.
* Recent vaccination
* Younger or older that inclusion criteria.
* Pregnancy.
What they're measuring
1
The percent of participants with salt sensitive blood pressure